HGHRX | VGHCX | HGHRX / VGHCX | |
Total Expense Ratio | 1.63 | 0.37 | 441% |
Annual Report Gross Expense Ratio | 1.63 | 0.37 | 441% |
Fund Existence | 19 years | 41 years | - |
Gain YTD | -4.684 | -3.575 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 771M | 36B | 2% |
Annual Yield % from dividends | 0.00 | 0.88 | - |
Returns for 1 year | -17.37 | -21.77 | 80% |
Returns for 3 years | -5.83 | -14.83 | 39% |
Returns for 5 years | -19.26 | -19.00 | 101% |
Returns for 10 years | -22.04 | -26.42 | 83% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RGEF | 28.43 | 0.48 | +1.72% |
Rockefeller Global Equity ETF | |||
IWS | 137.36 | 0.69 | +0.50% |
iShares Russell Mid-Cap Value ETF | |||
BAMY | 27.54 | 0.04 | +0.16% |
Brookstone Yield ETF | |||
MOTI | 36.02 | -0.10 | -0.27% |
VanEck Morningstar Intl Moat ETF | |||
GGN | 4.50 | -0.03 | -0.66% |
GAMCO Global Gold Natural Resources & Income Trust |